Related references
Note: Only part of the references are listed.SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
Meta Roestenberg et al.
LANCET (2011)
A Research Agenda for Malaria Eradication: Vaccines
Pedro L. Alonso et al.
PLOS MEDICINE (2011)
Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic
H. M. El Sahly et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria
Stephen L. Hoffman et al.
HUMAN VACCINES (2010)
Malaria 2010: more ambition and accountability please
The Lancet
LANCET (2010)
Plasmodium falciparum Malaria Challenge by the Bite of Aseptic Anopheles stephensi Mosquitoes: Results of a Randomized Infectivity Trial
Kirsten E. Lyke et al.
PLOS ONE (2010)
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
Kavita Tewari et al.
VACCINE (2010)
Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites
Nathan W. Schmidt et al.
PLOS PATHOGENS (2010)
Malaria vaccine research: lessons from 2008/9
Ashraful Haque et al.
FUTURE MICROBIOLOGY (2009)
The Potential Role of Vaccines in the Elimination of Falciparum Malaria and the Eventual Eradication of Malaria
Christopher V. Plowe et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Protection against a Malaria Challenge by Sporozoite Inoculation.
Meta Roestenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria
A. A. Holder
PARASITOLOGY (2009)
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
Kelley M. VanBuskirk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort
Thomas A. Gaziano et al.
LANCET (2008)
Malaria vaccines and their potential role in the elimination of malaria
Geoffrey A. Targett et al.
MALARIA JOURNAL (2008)
Gene Disruption of Plasmodium falciparum p52 Results in Attenuation of Malaria Liver Stage Development in Cultured Primary Human Hepatocytes
Ben C. L. van Schaijk et al.
PLOS ONE (2008)
Direct microscopic quantification of dynamics of plasmodium berghei sporozoite transmission from mosquitoes to mice
Yamei Jinj et al.
INFECTION AND IMMUNITY (2007)
Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A
Clara Brando et al.
INFECTION AND IMMUNITY (2007)
Quantitative imaging of Plasmodium transmission from mosquito to mammal
R Amino et al.
NATURE MEDICINE (2006)
Intracellular cytokine optimization and standard operating procedure
Laurie Lamoreaux et al.
NATURE PROTOCOLS (2006)
Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells
P Leiriao et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Additional observations on the sporozoite transmission of Plasmodium knowlesi to monkeys
WE Collins et al.
JOURNAL OF PARASITOLOGY (2004)
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
DL Doolan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
SJ McConkey et al.
NATURE MEDICINE (2003)
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine
TC Luke et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
A proteomic view of the Plasmodium falciparum life cycle
L Florens et al.
NATURE (2002)
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
SL Hoffman et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine
RB Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The complexity of protective immunity against liver-stage malaria
DL Doolan et al.
JOURNAL OF IMMUNOLOGY (2000)